Clinical Trial Update: Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers [Phase 3]

View source ↗

Summary

Long-term follow-up results from a Phase 3 trial evaluating a single-dose Japanese Encephalitis chimeric virus vaccine (JE-CV) in toddlers, focusing on immunoge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Encephalitis
• Japanese Encephalitis

Drugs mentioned

• JE-CV (Chimeric Japanese Encephalitis Vaccine) (Chimeric Japanese encephalitis vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Encephalitis, Japanese Encephalitis | Phase 3 | Status: COMPLETED | Results posted: 2017-11-29